Your browser doesn't support javascript.
loading
A Randomized, First-in-Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway.
Bartko, Johann; Schoergenhofer, Christian; Schwameis, Michael; Firbas, Christa; Beliveau, Martin; Chang, Colin; Marier, Jean-Francois; Nix, Darrell; Gilbert, James C; Panicker, Sandip; Jilma, Bernd.
Afiliação
  • Bartko J; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Schoergenhofer C; Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 1st Medical Department Hanusch Hospital, Vienna, Austria.
  • Schwameis M; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Firbas C; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Beliveau M; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Chang C; Certara Strategic Consulting, Montreal, Canada.
  • Marier JF; Certara Strategic Consulting, Montreal, Canada.
  • Nix D; Certara Strategic Consulting, Montreal, Canada.
  • Gilbert JC; Drug Development Consulting.
  • Panicker S; True North Therapeutics Inc., South San Francisco, California, USA (a Bioverativ company).
  • Jilma B; Bioverativ Therapeutics Inc., South San Francisco, California, USA.
Clin Pharmacol Ther ; 104(4): 655-663, 2018 10.
Article em En | MEDLINE | ID: mdl-29737533
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complemento C1s / Via Clássica do Complemento / Inativadores do Complemento / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complemento C1s / Via Clássica do Complemento / Inativadores do Complemento / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2018 Tipo de documento: Article